Skip to content
Compare stocks

Sanara MedTech vs Kestra Medical Technologies stock comparison

Score, categories, valuation, dividend, crash risk and price performance of Sanara MedTech and Kestra Medical Technologies side by side. Figures from the overnight run, closing prices from 19 Nov 2026.

Key figures compared

SMTISanara MedTechKMTSKestra Medical Technologies
MEQIRI Score
Score6139
Fundamentals3917
Growth7050
Profitability8717
Valuation48no data
Technical analysis7663
Momentum8764
Stability2952
Capital allocation4525
Price and valuation
Closing price$32.67$26.63
Market cap$300M$1.59B
P/ELossLoss
Forward P/Eno dataLoss expected
Fair value$36.27no data
Fair value versus price+11.0%no data
Growth and dividend
Revenue growth per year+45.9%no data
Dividend yield0.0%0.0%
Risk and performance
Crash riskhigh36 in 100no data
Price 1 year+71.4%+3.1%
Price 5 years+4.3%no data
IndustryMedical (Instruments & Supplies)Medical (Instruments & Supplies)

Score and figures from the overnight run, closing prices from 19 Nov 2026. Amounts in US dollars, converted at the ECB rate. Price performance without dividends. The comparison shows figures and is not a recommendation to buy.

Price performance

  • Sanara MedTech
  • Kestra Medical Technologies

All lines start at 100 on 6 March 2025, the first trading day of the youngest stock. Closing prices without dividends, each stock in its trading currency.

Questions and Answers

How do Sanara MedTech and Kestra Medical Technologies compare on the MEQIRI Score?

The MEQIRI Score (0 to 100) is 61 for Sanara MedTech and 39 for Kestra Medical Technologies. The category Profitability differs most, with 87 for Sanara MedTech and 17 for Kestra Medical Technologies. The score combines eight categories and is recalculated every night.

What is the P/E ratio of Sanara MedTech and Kestra Medical Technologies?

Sanara MedTech: P/E Loss, forward P/E no data. Kestra Medical Technologies: P/E Loss, forward P/E Loss expected. As of the close on 19 Nov 2026.

What is the dividend yield of Sanara MedTech and Kestra Medical Technologies?

Sanara MedTech: 0.0%. Kestra Medical Technologies: 0.0%. Based on payments over the last twelve months.

What is the crash risk of Sanara MedTech and Kestra Medical Technologies?

Sanara MedTech: Crash risk high (36 in 100). Kestra Medical Technologies: no data. Crash risk means a fall of 30% or more within a year, measured in the backtest against companies of similar size.

Why does the price chart start at 100?

All lines start at 100 on the same day. That shows performance regardless of a stock's price: 150 means 50% more than at the start, 80 means 20% less.

Does the comparison tell me which stock to buy?

No. MEQIRI shows figures and explains them, but gives no buy recommendation and no price target. The score helps you see strengths and weaknesses faster.

More comparisons

Compare stocks